|Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer|
P Jabbarzadeh Kaboli, A Rahmat, P Ismail, KH Ling
European Journal of Pharmacology 740, 584-595, 2014
|MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment|
PJ Kaboli, A Rahmat, P Ismail, KH Ling
Pharmacological research 97, 104-121, 2015
|An ethnobotanical survey of medicinal plants used by indigenous people in Zangelanlo district, Northeast Iran|
MS Amiri, P Jabbarzadeh, M Akhondi
Journal of Medicinal Plants Research 6 (5), 749-753, 2012
|Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study|
PJ Kaboli, MPY Leong, P Ismail, KH Ling
Pharmacological Reports 71 (1), 13-23, 2019
|Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: a new group of RAF inhibitors for cancer treatment|
P Jabbarzadeh Kaboli, P Ismail, KH Ling
PloS one 13 (3), e0193941, 2018
|m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer|
Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu, J Yin, H Zhang, Y Wu, ...
Translational oncology 12 (10), 1323-1333, 2019
|Molecular modelling of berberine derivatives as inhibitors of human smoothened receptor and hedgehog signalling pathway using a newly developed algorithm on anti-cancer drugs|
PJ Kaboli, M Bazrafkan, P Ismail, KH Ling
Recent patents on anti-cancer drug discovery 12 (4), 384-400, 2017
|Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer–contradictory effects and future perspectives|
PJ Kaboli, MA Khoshkbejari, M Mohammadi, A Abiri, R Mokhtarian, ...
Biomedicine & Pharmacotherapy 121, 109635, 2020
|PIK3CA rs7640662 (C/G) single nucleotide polymorphism lacks association with breast cancer cases in Persians|
A Mir, M Sadegh, Z Ahmadinia, P Jabbarzadeh Kaboli
Interventional Medicine and Applied Science 7 (1), 3-8, 2015
|Floristic study of Zangelanlo watershed (Khorassan, Iran)|
MS AMIRI, P JABBARZADEH
JOURNAL OF TAXONOMY AND BIOSISTEMATICS 2 (5), 1-15, 2011
|Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy|
PJ Kaboli, F Salimian, S Aghapour, S Xiang, Q Zhao, M Li, X Wu, F Du, ...
Pharmacological Research, 104806, 2020
|Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets|
D Li, S Xiang, J Shen, M Xiao, Y Zhao, X Wu, F Du, H Ji, M Li, Q Zhao, ...
International journal of biological sciences 16 (4), 568, 2020
|Molecular markers of regulatory t cells in cancer immunotherapy with special focus on acute myeloid leukemia (AML)-a systematic review|
PJ Kaboli, L Zhang, S Xiang, J Shen, M Li, Y Zhao, X Wu, Q Zhao, ...
Current Medicinal Chemistry, 2020
|A Novel One-Click Automated Drug Discovery tool: A New Approach Based on Binding Efficiency Indices|
PJ Kaboli, M Bazrafkan, P Ismail, KH Ling
The FASEB Journal 31 (1_supplement), 818.7-818.7, 2017
|A review of Penthorum chinense Pursh for hepatoprotection: Traditional use, phytochemistry, pharmacology, toxicology and clinical trials|
A Wang, M Li, H Huang, Z Xiao, J Shen, Y Zhao, J Yin, PJ Kaboli, J Cao, ...
Journal of Ethnopharmacology 251, 112569, 2020
|Characterization of chemical composition and prebiotic effect of a dietary medicinal plant Penthorum chinense Pursh|
J Yin, W Ren, B Wei, H Huang, M Li, X Wu, A Wang, Z Xiao, J Shen, ...
Food Chemistry, 126568, 2020
|Conditional reprogramming: next generation cell culture|
X Wu, S Wang, M Li, J Li, J Shen, Y Zhao, J Pang, Q Wen, M Chen, B Wei, ...
Acta Pharmaceutica Sinica B, 2020
|Lapatinib as a dual tyrosine kinase inhibitor unexpectedly activates akt in MDA-MB-231 triple-negative breast Cancer cells|
PJ Kaboli, KH Ling
Letters in Drug Design & Discovery 17, 000-000, 2020
|Berberine Derivatives as Multi-Kinase Inhibitors of MAP Kinase and PI3K Pathways: Molecular Modelling, Molecular Dynamics Simulations, and in vitro Evaluation|
PJ Kaboli, P Ismail, KH Ling
The FASEB Journal 31 (1_supplement), 671.12-671.12, 2017
|CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells|
J Yin, H Zhang, X Wu, Y Zhang, J Li, J Shen, Y Zhao, Z Xiao, L Lu, ...
International journal of molecular medicine 45 (6), 1783-1792, 2020